Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

NCT: NCT07569575 · NOT_YET_RECRUITING

NCT IDNCT07569575
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2027-12-31

Brief Summary

This is a prospective, multicenter, randomized, controlled, non-inferiority clinical trial designed to evaluate the safety and effectiveness of the magnesium-titanium hybrid intramedullary nail system compared with the marketed metal locked intramedullary nail in the treatment of long bone fractures of the extremities.

Frequently Asked Questions

What is Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures?

Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures is a clinical trial registered under NCT07569575. Current status: NOT_YET_RECRUITING.

What is the status of NCT07569575?

The current status of NCT07569575 (Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures) is: NOT_YET_RECRUITING.

When did Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures start?

Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑